Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Applications of arctigenin on preparing drugs for curing atherosclerosis or myocardial infarction

A technology of atherosclerosis and arctigenin, which is applied in the field of medicine to achieve good therapeutic effects, overcome the first-pass effect, and have obvious effects

Active Publication Date: 2014-01-01
LUNAN PHARMA GROUP CORPORATION
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Arctigenin has significant antibacterial, antiviral, antitumor, and anti-PAF receptor effects, but there is no report that arctigenin can treat atherosclerosis or myocardial infarction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Applications of arctigenin on preparing drugs for curing atherosclerosis or myocardial infarction
  • Applications of arctigenin on preparing drugs for curing atherosclerosis or myocardial infarction
  • Applications of arctigenin on preparing drugs for curing atherosclerosis or myocardial infarction

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] The preparation of embodiment 1 tablet

[0035]

[0036] Preparation process: mix arctigenin, auxiliary materials microcrystalline cellulose and sodium carboxymethyl starch evenly, add appropriate amount of starch slurry to make soft material, and pass through a 16-mesh sieve to granulate. The wet granules are dried at 60°C, the dry granules are passed through a 20-mesh sieve for granulation, the fine powder in the dry granules is screened out, mixed with magnesium stearate, and then mixed with the dry granules, pressed into tablets, each tablet is about 200mg, that is, .

Embodiment 2

[0037] The preparation of embodiment 2 injection

[0038] Arctigenin 10g

[0039] Tween 80 1g

[0040] Paraffin water for injection 1000mL

[0041] Preparation process: Mix 10g arctigenin and 1g Tween evenly, add water for injection to 1000mL, and divide into packages.

Embodiment 3

[0042] The preparation of embodiment 3 capsules

[0043] Arctigenin 100g

[0044] Lactose 120g

[0045] Cornstarch 130g

[0046] Magnesium Stearate 5g

[0047] Preparation process: 100g of arctigenin, 120g of lactose and 130g of corn starch are mixed in a mixer for 10-15 minutes, 5g of magnesium stearate is added and mixed for 1-3 minutes, and then filled into 1000 capsule shells.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses applications of arctigenin on preparing drugs for curing atherosclerosis or myocardial infarction, and belongs to the field of medicine. In the novel medical application disclosed by the invention of arctigenin, the dosage amount of arctigenin is 0.001 to 200 mg / kg for each day, arctigenin can be made into oral preparations, injection preparations, or external preparations, wherein the oral micro-emulsion preparation of arctigenin has the best effect. The arctigenin has the advantages of little by-effect, prominent curing advantage, and high drug compliance of patients, and has a very vast medical application prospect.

Description

technical field [0001] The invention belongs to the field of medicine, in particular to a medicine for treating atherosclerosis or myocardial infarction. Background technique [0002] Atherosclerosis (Arteriosclerosis, AS) is a systemic disease related to lipid metabolism disorders, characterized by lipid deposition in the intima of large and medium arteries, atherosclerotic plaque formation, fibrous tissue hyperplasia, and arterial wall sclerosis. The harm of atherosclerosis can lead to vascular stasis and narrowing and insufficient blood supply on the one hand, and on the other hand, the greater harm lies in the rupture of plaques and the formation of thrombus, resulting in tissue ischemia and hypoxia, and in severe cases, death of patients. Patients with atherosclerosis are more common in the elderly. The detection rates of AS in 40-49 years old are 58.36% and 88.31% respectively, and increase with age. It is a common disease that seriously endangers human health. Among t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/365A61P9/10
Inventor 赵志全姚景春王恩力孙敬侠刘奋董艳红
Owner LUNAN PHARMA GROUP CORPORATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com